The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
- 8 August 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 122 (6) , 922-931
Abstract
Key Points: BTLA-HVEM interaction negatively regulates the proliferation of LTγδ. BTLA-HVEM interaction appears as a new possible mechanism of immune escape by lymphoma cells.Keywords
This publication has 51 references indexed in Scilit:
- High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosisLeukemia, 2011
- B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their FunctionThe Journal of Immunology, 2010
- Cutting Edge: CTLA-4–B7 Interaction Suppresses Th17 Cell DifferentiationThe Journal of Immunology, 2010
- Putting the brakes on BTLA in T cell–mediated cancer immunotherapyJournal of Clinical Investigation, 2010
- BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationJournal of Clinical Investigation, 2010
- T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding MicroenvironmentThe Journal of Immunology, 2009
- Unconventional ligand activation of herpesvirus entry mediator signals cell survivalProceedings of the National Academy of Sciences, 2009
- Development of autoimmune hepatitis–like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuatorArthritis & Rheumatism, 2008
- A crucial role for HVEM and BTLA in preventing intestinal inflammationJournal of Experimental Medicine, 2008
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003